Tandem Capital Management’s Unicycive Therapeutics UNCY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,550	Closed	-$8.91K	–	119
2025 Q1	$8.91K	Hold	1,550	–	–	0.01%	113
2024 Q4	$12.3K	Hold	1,550	–	–	0.01%	112
2024 Q3	$6.32K	Hold	1,550	–	–	﹤0.01%	115
2024 Q2	$7.08K	Hold	1,550	–	–	﹤0.01%	112
2024 Q1	$21.4K	Hold	1,550	–	–	0.01%	109
2023 Q4	$13.4K	Hold	1,550	–	–	0.01%	111
2023 Q3	$13.3K	Hold	1,550	–	–	0.01%	107
2023 Q2	$19.8K	Hold	1,550	–	–	0.01%	107
2023 Q1	$32.5K	Hold	1,550	–	–	0.02%	105
2022 Q4	$8.37K	Hold	1,550	–	–	0.01%	96
2022 Q3	$10K	Hold	1,550	–	–	0.01%	91
2022 Q2	$13K	Hold	1,550	–	–	0.01%	91
2022 Q1	$17K	Hold	1,550	–	–	0.01%	93
2021 Q4	$32K	Hold	1,550	–	–	0.02%	92
2021 Q3	$44K	Buy	+1,550	New	+$44.5K	0.03%	87